Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Injectable Sumatriptan Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Top Injectable Sumatriptan Manufacturers Covered: Ranking by Revenue
  • 1.3 Market Segment by Type
    • 1.3.1 Global Injectable Sumatriptan Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
    • 1.3.2 4mg
    • 1.3.3 6mg
    • 1.3.4 Others
  • 1.4 Market Segment by Application
    • 1.4.1 Global Injectable Sumatriptan Consumption by Application: 2015 VS 2020 VS 2026
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Market Perspective

  • 2.1 Global Injectable Sumatriptan Revenue (2015-2026)
    • 2.1.1 Global Injectable Sumatriptan Revenue (2015-2026)
    • 2.1.2 Global Injectable Sumatriptan Sales (2015-2026)
  • 2.2 Global Injectable Sumatriptan Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
    • 2.2.1 Global Injectable Sumatriptan Sales by Regions (2015-2020)
    • 2.2.2 Global Injectable Sumatriptan Revenue by Regions (2015-2020)
  • 2.3 Global Top Injectable Sumatriptan Regions (Countries) Ranking by Market Size
  • 2.4 Injectable Sumatriptan Industry Trends
    • 2.4.1 Injectable Sumatriptan Market Trends
    • 2.4.2 Injectable Sumatriptan Market Drivers
    • 2.4.3 Injectable Sumatriptan Market Challenges
    • 2.4.4 Injectable Sumatriptan Market Restraints
    • 2.4.5 Primary Interviews with Key Injectable Sumatriptan Players: Views for Future

3 Competitive Landscape by Manufacturers

  • 3.1 Global Top Injectable Sumatriptan Manufacturers by Sales (2015-2020)
    • 3.1.1 Global Injectable Sumatriptan Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Injectable Sumatriptan Sales Market Share by Manufacturers (2015-2020)
    • 3.1.3 Global 5 and 10 Largest Manufacturers by Injectable Sumatriptan Sales in 2019
  • 3.2 Global Top Manufacturers Injectable Sumatriptan by Revenue
    • 3.2.1 Global Injectable Sumatriptan Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Injectable Sumatriptan Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Injectable Sumatriptan Market Concentration Ratio (CR5 and HHI)
  • 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Sumatriptan as of 2019)
  • 3.4 Global Injectable Sumatriptan Average Selling Price (ASP) by Manufacturers
  • 3.5 Key Manufacturers Injectable Sumatriptan Plants/Factories Distribution and Area Served
  • 3.6 Date of Key Manufacturers Enter into Injectable Sumatriptan Market
  • 3.7 Key Manufacturers Injectable Sumatriptan Product Offered
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Injectable Sumatriptan Historic Market Review by Type (2015-2020)
    • 4.1.2 Global Injectable Sumatriptan Sales Market Share by Type (2015-2020)
    • 4.1.3 Global Injectable Sumatriptan Revenue Market Share by Type (2015-2020)
    • 4.1.4 Injectable Sumatriptan Price by Type (2015-2020)
  • 4.1 Global Injectable Sumatriptan Market Estimates and Forecasts by Type (2021-2026)
    • 4.2.2 Global Injectable Sumatriptan Sales Forecast by Type (2021-2026)
    • 4.2.3 Global Injectable Sumatriptan Revenue Forecast by Type (2021-2026)
    • 4.2.4 Injectable Sumatriptan Price Forecast by Type (2021-2026)

5 Global Injectable Sumatriptan Market Size by Application

  • 5.1 Global Injectable Sumatriptan Historic Market Review by Application (2015-2020)
    • 5.1.2 Global Injectable Sumatriptan Sales Market Share by Application (2015-2020)
    • 5.1.3 Global Injectable Sumatriptan Revenue Market Share by Application (2015-2020)
    • 5.1.4 Injectable Sumatriptan Price by Application (2015-2020)
  • 5.2 Global Injectable Sumatriptan Market Estimates and Forecasts by Application (2021-2026)
    • 5.2.2 Global Injectable Sumatriptan Sales Forecast by Application (2021-2026)
    • 5.2.3 Global Injectable Sumatriptan Revenue Forecast by Application (2021-2026)
    • 5.2.4 Injectable Sumatriptan Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Injectable Sumatriptan Breakdown Data by Company
  • 6.2 North America Injectable Sumatriptan Breakdown Data by Type
  • 6.3 North America Injectable Sumatriptan Breakdown Data by Application
  • 6.4 North America Injectable Sumatriptan Breakdown Data by Countries
    • 6.4.1 North America Injectable Sumatriptan Sales by Countries
    • 6.4.2 North America Injectable Sumatriptan Revenue by Countries
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Injectable Sumatriptan Breakdown Data by Company
  • 7.2 Europe Injectable Sumatriptan Breakdown Data by Type
  • 7.3 Europe Injectable Sumatriptan Breakdown Data by Application
  • 7.4 Europe Injectable Sumatriptan Breakdown Data by Countries
    • 7.4.1 Europe Injectable Sumatriptan Sales by Countries
    • 7.4.2 Europe Injectable Sumatriptan Revenue by Countries
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Injectable Sumatriptan Breakdown Data by Company
  • 8.2 Asia Pacific Injectable Sumatriptan Breakdown Data by Type
  • 8.3 Asia Pacific Injectable Sumatriptan Breakdown Data by Application
  • 8.4 Asia Pacific Injectable Sumatriptan Breakdown Data by Regions
    • 8.4.1 Asia Pacific Injectable Sumatriptan Sales by Regions
    • 8.4.2 Asia Pacific Injectable Sumatriptan Revenue by Regions
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Taiwan
    • 8.4.9 Indonesia
    • 8.4.10 Thailand
    • 8.4.11 Malaysia
    • 8.4.12 Philippines
    • 8.4.13 Vietnam

9 Latin America

  • 9.1 Latin America Injectable Sumatriptan Breakdown Data by Company
  • 9.2 Latin America Injectable Sumatriptan Breakdown Data by Type
  • 9.3 Latin America Injectable Sumatriptan Breakdown Data by Application
  • 9.4 Latin America Injectable Sumatriptan Breakdown Data by Countries
    • 9.4.1 Latin America Injectable Sumatriptan Sales by Countries
    • 9.4.2 Latin America Injectable Sumatriptan Revenue by Countries
    • 9.4.3 Mexico
    • 9.4.4 Brazil
    • 9.4.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Injectable Sumatriptan Breakdown Data by Type
  • 10.2 Middle East and Africa Injectable Sumatriptan Breakdown Data by Application
  • 10.3 Middle East and Africa Injectable Sumatriptan Breakdown Data by Countries
    • 10.3.1 Middle East and Africa Injectable Sumatriptan Sales by Countries
    • 10.3.2 Middle East and Africa Injectable Sumatriptan Revenue by Countries
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia
    • 10.3.5 U.A.E

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Business Overview
    • 11.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Injectable Sumatriptan Products and Services
    • 11.1.5 GlaxoSmithKline SWOT Analysis
    • 11.1.6 GlaxoSmithKline Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Injectable Sumatriptan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Injectable Sumatriptan Products and Services
    • 11.2.5 Pfizer SWOT Analysis
    • 11.2.6 Pfizer Recent Developments
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Business Overview
    • 11.3.3 Teva Injectable Sumatriptan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
    • 11.3.4 Teva Injectable Sumatriptan Products and Services
    • 11.3.5 Teva SWOT Analysis
    • 11.3.6 Teva Recent Developments
  • 11.4 Sun Pharma
    • 11.4.1 Sun Pharma Corporation Information
    • 11.4.2 Sun Pharma Business Overview
    • 11.4.3 Sun Pharma Injectable Sumatriptan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
    • 11.4.4 Sun Pharma Injectable Sumatriptan Products and Services
    • 11.4.5 Sun Pharma SWOT Analysis
    • 11.4.6 Sun Pharma Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Injectable Sumatriptan Value Chain Analysis
  • 12.2 Sales Channels Analysis
    • 12.2.1 Injectable Sumatriptan Sales Channels
    • 12.2.2 Injectable Sumatriptan Distributors
  • 12.3 Injectable Sumatriptan Customers

13 Estimates and Projections by Regions (2021-2026)

  • 13.1 Global Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.1.1 Global Injectable Sumatriptan Sales Forecast by Regions (2021-2026)
    • 13.1.2 Global Injectable Sumatriptan Revenue Forecast by Regions (2021-2026)
  • 13.2 North America Market Size Forecast (2021-2026)
    • 13.2.1 North America Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.2.2 North America Injectable Sumatriptan Revenue Forecast (2021-2026)
    • 13.2.3 North America Injectable Sumatriptan Size Forecast by County (2021-2026)
  • 13.3 Europe Market Size Forecast (2021-2026)
    • 13.3.1 Europe Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.3.2 Europe Injectable Sumatriptan Revenue Forecast (2021-2026)
    • 13.3.3 Europe Injectable Sumatriptan Size Forecast by County (2021-2026)
  • 13.4 Asia Pacific Market Size Forecast (2021-2026)
    • 13.4.1 Asia Pacific Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.4.2 Asia Pacific Injectable Sumatriptan Revenue Forecast (2021-2026)
    • 13.4.3 Asia Pacific Injectable Sumatriptan Size Forecast by Region (2021-2026)
  • 13.5 Latin America Market Size Forecast (2021-2026)
    • 13.5.1 Latin America Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.5.2 Latin America Injectable Sumatriptan Revenue Forecast (2021-2026)
    • 13.5.3 Latin America Injectable Sumatriptan Size Forecast by County (2021-2026)
  • 13.6 Middle East and Africa Market Forecast
    • 13.6.1 Middle East and Africa Injectable Sumatriptan Sales Forecast (2021-2026)
    • 13.6.2 Middle East and Africa Injectable Sumatriptan Revenue Forecast (2021-2026)
    • 13.6.3 Middle East and Africa Injectable Sumatriptan Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Sumatriptan injection comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use sumatriptan but return after 1 hour or longer, you may use a second dose of sumatriptan.
    The global Injectable Sumatriptan market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    In terms of production side, this report researches the Injectable Sumatriptan production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
    In terms of consumption side, this report focuses on the consumption of Injectable Sumatriptan by regions (countries) and by Application.
    The global Injectable Sumatriptan market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Injectable Sumatriptan market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
    Geographic Segmentation
    The report offers exhaustive assessment of different region-wise Injectable Sumatriptan markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
    For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Injectable Sumatriptan market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
    Manufacturers
    The report includes comprehensive company profiling of leading and emerging companies competing in the global Injectable Sumatriptan market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Injectable Sumatriptan market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
    By Type and Application Segments
    The report includes a detailed analysis of leading and type and application segments of the global Injectable Sumatriptan market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Injectable Sumatriptan market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Injectable Sumatriptan market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Injectable Sumatriptan market by each application segment for the same period.
    This report includes the following manufacturers:
    GlaxoSmithKline
    Pfizer
    Teva
    Sun Pharma
    ...
    Market Segment by Type
    4mg
    6mg
    Others
    Market Segment by Application
    Hospitals
    Clinics
    Others
    Research Methodology
    To compile the detailed study of the global Injectable Sumatriptan market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Injectable Sumatriptan market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Injectable Sumatriptan market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
    Buy now